Advertisement

Browse Subject Areas

?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

Drug regulation

Sino-US-DrugQA: A benchmark for evaluating large language models in cross-jurisdictional pharmaceutical regulation

Xuejing Fu, Zhen Chen, Wentao Lu

Stakeholder-informed pre-implementation refinement of a pharmacy-led pre-exposure prophylaxis (PrEP) service delivery model in Malaysia

Yan Nee Gan, Sin How Lim, [ ... ], Rafdzah Zaki

Expedited pathway portfolios, trial complexity, and FDA approval timelines in oncology and neurology: A comparative analysis

Ahmed M. Sayed, Nada M. Ezzelarab, Nguyen Tien Huy

Changes in evidence used for FDA Novel Drug Approvals: 2016-2024

Aditya Narayan, Veronica L. Irvin, [ ... ], Robert M. Kaplan

In vitro dissolution and release kinetics of multisource ciprofloxacin 500 mg tablets in West Gondar, Ethiopia: Implications for interchangeability and regulatory oversight

Tewodros Denekew Haile, Ayenew Ashenef, [ ... ], Melaku Getahun Feleke

Towards sustainable pharmacy practice: Community pharmacists’ experiences with medicine waste, reuse and disposal

Kingston Rajiah, Ellen McLaughlin

Commercial cannabis product testing: Fidelity to labels and regulations

Sarah A. Limbacher, Suneeta Godbole, [ ... ], Ashley Brooks-Russell

Evaluating community pharmacists’ involvement in patient counselling and health education in Nairobi, Kenya: A cross-sectional study

Seraphine Wanjiro Manjari, Mergia Terefe Ermias

Perceptions and practices on substandard and falsified medicines in humans and animals in Wakiso district, Uganda: A qualitative study

David Musoke, Grace Biyinzika Lubega, [ ... ], Linda Gibson

Extent and causes of the collapse in the registration of innovative medications in Lebanon: A mixed-methods analysis

Wadih Mina, Hanadi Nahas, [ ... ], Soumana C. Nasser

The use of international comparison as interactive teaching method in pharmacy education

Jawza Alsabhan, Hailah Almoghirah, Noha Alaloola

Impact of pregabalin reclassification as a controlled substance in Egypt on gabapentinoid and opioid utilization: A repeated cross-sectional study

Araniy Santhireswaran, Simon LaRue, [ ... ], Mina Tadrous

The impact of ESG performance on corporate innovation—Empirical evidence from Chinese pharmaceutical listed companies

Liqiang Li, Su Wang, Yuwen Chen

Advertisement

Create a weekly email alert for: Drug regulation

You can change these options by clicking profile then "Alerts and Notifications"